DoMore, Proscia partner to predict patient outcomes in colorectal cancer
The partnership will combine DoMore’s CE-IVDD marked Histotype Px Colorectal digital biomarker with Proscia’s CE-IVDR marked Concentriq Dx…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
31 Aug 23
The partnership will combine DoMore’s CE-IVDD marked Histotype Px Colorectal digital biomarker with Proscia’s CE-IVDR marked Concentriq Dx…
31 Aug 23
As a ComboMATCH-designated lab, Exact Sciences will use its OncoExTra test to examine tumour tissue and associated normal…
31 Aug 23
Quest and Sarepta Therapeutics Expand Collaboration to Develop AAV Companion Diagnostics (CDx) for Sarepta's Gene Therapies
30 Aug 23
The partnership aims to manufacture medical diagnostic devices that rapidly detect and differentiate multiple infections, and uses printed…
30 Aug 23
CobiCure intends to provide strategic support, resources, and funding to advance the development of PolyVascular's polymer heart valve…
30 Aug 23
The first implantation procedure of Amvia Edge was conducted at Mount Sinai Medical Center in Miami, Florida by…
30 Aug 23
Company says Tala is their most innovative hearing enhancement product to date, with multiple industry leading features, including…
30 Aug 23
This marks the first use of the VASCADE system portfolio, widely used in U.S. hospitals, in a European…
30 Aug 23
The extended agreement covers any European country
29 Aug 23
The Percutaneous Module 2.0 provides new planning features and enhanced functionality for the 7D FLASH Navigation System, which…